Hims & Hers, the US-based telehealth platform, has acquired Australian digital health platform Eucalyptus in a US$1.15 billion deal, its largest acquisition to date.
HBI’s first ever Special Report on private medical insurance (PMI) features analysis and commentary from various experts on the shifting nature of the PMI industry, the growth opportunities and the different avenues of innovation that are being pursued, as well as in depth case study interviews with three different PMI companies at the forefront of this: Vitality, Bupa and Alan.
Ramsay Health Care, Australia’s largest private hospital group, has announced plans to separate its European arm, Ramsay Santé, by distributing its shares directly to its existing shareholders through an in-specie distribution.
HBI spoke to PA Consulting’s digital healthcare expert, Andrew Earnshaw, about what the gap between NHS infrastructure and the growing demand for preventative care means for private healthcare and where the opportunity for private capital lies.
Orthalis, a French software company focused on orthodontics, has acquired Dentalsoft Group, a French provider of software and IT services to dental practices.
Pan-European diagnostic labs group Synlab has exited another market. It has sold its Slovakian operations to Unilabs, another pan-European diagnostics group, as part of its strategy to “densify its network”.
Medica, the UK’s largest teleradiology company, has bought one of its smaller competitors, Axon Diagnostics. HBI caught up with Andrew Cannon, Medica’s CEO, to discuss the acquisition and Medica’s plans for the future.
Italian insurer Reale Mutua is set to buy an 80% stake in Lifenet Healthcare, a hospital and outpatient services group in the north of the country, from Exor, the investment firm owned by the Agnelli family, and the company’s founder, in a deal reportedly worth around €600 million.
Alantra, a Spanish private equity firm focused on mid-market transactions, has closed a €155 million healthcare continuation fund to support the next phase of growth at Health in Code (HiC), a clinical genomics company it has backed since 2020. The fund was oversubscribed and led by Hayfin Capital Management, a London-headquartered lending firm, alongside other […]
GLP-1 weight loss drugs are now widely used in the UK, with around 2.5 million people taking them. The market has grown fast, raising questions about how safely these medications are prescribed and how much support patients receive. NHS access is still limited and varies depending on where you live. As a result, many people are choosing to go private.
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.
